Prostate Cancer Misdiagnosis Elimination Act of 2017

United States115th CongressHR-2557House of Representatives
Updated: Dec 6, 2017

Summary

Prostate Cancer Misdiagnosis Elimination Act of 2017 This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.

Bill texts

Available versions
View official text

2 versions available

All available records shown.

Timeline

  1. Ordered to be Reported (Amended) by Voice Vote.

    House of Representatives

  2. Committee on Ways and Means discharged.

    House of Representatives

  3. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-449, Part I.

    House of Representatives

  4. Placed on the Union Calendar, Calendar No. 331.

    House of Representatives